Surgi-Vision gets FDA clearance for internal MRI coil

By staff writers

December 4, 2000 --

Surgi-Vision has received Food and Drug Administration 510(k) clearance for its Intercept - Prostate micro-coil. Intercept will join two other FDA-cleared coils, Intercept – Esophagus and Intercept – Urethra, in the Columbia, MD-based firm’s product line of internal MRI micro-coils.

Surgi-Vision’s technology was developed in coordination with biomedical engineers and radiologists from Johns Hopkins University School of Medicine in Baltimore.

By staff writers
December 1, 2000

Related Reading

Surgi-Vision wins clearance for MRI coil, October 26, 2000

Copyright © 2000


To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking